Table 6.
Summary of the SF-8 in the Intention-to-Treat Population
| Group | Baseline | Week 24 | P value | |
|---|---|---|---|---|
| Number of participants | M | 134 | 128 | |
| P | 134 | 125 | ||
| SF-8 (PCS) | M | 61.97 (7.63) | 62.90 (8.16) | 0.263 |
| P | 62.31 (7.15) | 62.41 (8.17) | ||
| SF-8 (MCS) | M | 51.90 (5.12) | 50.92 (5.32) | 0.233 |
| P | 52.01 (4.75) | 50.48 (5.59) |
Notes: Data represent numbers or means (with standard deviations). P values were derived by the analysis of covariance (the scores at week 24 were adjusted for the baseline score).
Abbreviations: SF-8, Short Form-8; M, Met-Lys-Pro; P, placebo; PCS, Physical Component Summary; MCS, Mental Component Summary.